| Product Code: ETC12568716 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The Netherlands continues to import a significant amount of long-acting insulin, with key suppliers in 2024 being Germany, USA, Ireland, Belgium, and Italy. Despite moderate concentration levels measured by the Herfindahl-Hirschman Index (HHI), the market is showing steady growth with a compound annual growth rate (CAGR) of 5.02% from 2020 to 2024. The growth rate in 2024 stands at 0.84%, indicating a consistent demand for long-acting insulin in the country.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Long Acting Insulin Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Long Acting Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Long Acting Insulin Market - Industry Life Cycle |
3.4 Netherlands Long Acting Insulin Market - Porter's Five Forces |
3.5 Netherlands Long Acting Insulin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Netherlands Long Acting Insulin Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.7 Netherlands Long Acting Insulin Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
3.8 Netherlands Long Acting Insulin Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
4 Netherlands Long Acting Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in the Netherlands |
4.2.2 Growing awareness about the benefits of long-acting insulin in managing diabetes |
4.2.3 Technological advancements leading to the development of more effective long-acting insulin products |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval of long-acting insulin products |
4.3.2 Competition from alternative diabetes management therapies |
4.3.3 Price sensitivity among consumers due to the high cost of long-acting insulin products |
5 Netherlands Long Acting Insulin Market Trends |
6 Netherlands Long Acting Insulin Market, By Types |
6.1 Netherlands Long Acting Insulin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Long Acting Insulin Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Netherlands Long Acting Insulin Market Revenues & Volume, By Lantus, 2021 - 2031F |
6.1.4 Netherlands Long Acting Insulin Market Revenues & Volume, By Levemir, 2021 - 2031F |
6.1.5 Netherlands Long Acting Insulin Market Revenues & Volume, By Tresiba, 2021 - 2031F |
6.1.6 Netherlands Long Acting Insulin Market Revenues & Volume, By Basaglar, 2021 - 2031F |
6.1.7 Netherlands Long Acting Insulin Market Revenues & Volume, By Toujeo, 2021 - 2031F |
6.2 Netherlands Long Acting Insulin Market, By Delivery Method |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Long Acting Insulin Market Revenues & Volume, By Pen, 2021 - 2031F |
6.2.3 Netherlands Long Acting Insulin Market Revenues & Volume, By Syringe, 2021 - 2031F |
6.2.4 Netherlands Long Acting Insulin Market Revenues & Volume, By Pump, 2021 - 2031F |
6.2.5 Netherlands Long Acting Insulin Market Revenues & Volume, By Pre-filled Device, 2021 - 2031F |
6.3 Netherlands Long Acting Insulin Market, By Patient Type |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Long Acting Insulin Market Revenues & Volume, By Type 1 Diabetes, 2021 - 2031F |
6.3.3 Netherlands Long Acting Insulin Market Revenues & Volume, By Type 2 Diabetes, 2021 - 2031F |
6.3.4 Netherlands Long Acting Insulin Market Revenues & Volume, By Gestational Diabetes, 2021 - 2031F |
6.4 Netherlands Long Acting Insulin Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Long Acting Insulin Market Revenues & Volume, By Solution, 2021 - 2031F |
6.4.3 Netherlands Long Acting Insulin Market Revenues & Volume, By Suspension, 2021 - 2031F |
7 Netherlands Long Acting Insulin Market Import-Export Trade Statistics |
7.1 Netherlands Long Acting Insulin Market Export to Major Countries |
7.2 Netherlands Long Acting Insulin Market Imports from Major Countries |
8 Netherlands Long Acting Insulin Market Key Performance Indicators |
8.1 Patient adherence rate to long-acting insulin therapy |
8.2 Number of clinical trials conducted for new long-acting insulin products |
8.3 Rate of adoption of long-acting insulin therapy among healthcare providers |
9 Netherlands Long Acting Insulin Market - Opportunity Assessment |
9.1 Netherlands Long Acting Insulin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Netherlands Long Acting Insulin Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
9.3 Netherlands Long Acting Insulin Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
9.4 Netherlands Long Acting Insulin Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
10 Netherlands Long Acting Insulin Market - Competitive Landscape |
10.1 Netherlands Long Acting Insulin Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Long Acting Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here